Spatial Metabolic Regulation in Kidney Repair
SPARK aims to explore how disrupted kidney cell metabolism affects injury and repair, utilizing multi-omics to identify targets for improving chronic kidney disease treatments.
Projectdetails
Introduction
Chronic kidney disease (CKD) is a global health concern, and the limited treatment options for end-stage kidney disease have remained unchanged for decades. Concurrent insults to the kidney can exacerbate disease progression, but the underlying potential to have kidney repair after such injury remains poorly understood.
Background
The tricarboxylic acid (TCA) cycle, a fundamental metabolic pathway, plays a vital role in energy production and biomolecule synthesis. Recent research by my group has revealed that failed repair and subsequent fibrosis in kidney epithelial cells are linked to anaplerotic failure in the TCA cycle, resulting in the inability to maintain sufficient levels of TCA intermediates.
Metabolic Regulation
These metabolites regulate chromatin remodeling and cell signaling pathways, influencing cell fate decisions. SPARK aims to investigate the impact of perturbed cell metabolism and metabolic crosstalk within kidney microenvironments on cell fate decisions during injury and repair.
Project Objectives
The project will:
- Map the metabolic, proteomic, and transcriptomic interactome at an unprecedented resolution, focusing on the kidney tissue microenvironment.
- Integrate spatial multi-omics data, exometabolite interactome analysis, and human kidney biopsies to identify actionable targets.
- Validate the metabolic effects of the selected targets through in vivo studies using reporter mice and ex vivo preserved human kidneys.
Expected Outcomes
This research will provide insights into how the metabolic interactome governs repair through epigenetic modulations in the kidney and establish a paradigm for studying tissue homeostasis in various contexts.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.500.000 |
Totale projectbegroting | € 2.500.000 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- ACADEMISCH ZIEKENHUIS LEIDENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney diseaseTargetCKD aims to revolutionize chronic kidney disease management by developing noninvasive diagnostics and novel therapeutics through advanced genomic technologies and interdisciplinary research. | ERC Consolid... | € 1.999.063 | 2022 | Details |
Functional Measurements IN-THE-KIDNEY to Diagnose, Understand and Treat Renal TubulopathiesThis project aims to develop urine-based diagnostics and patient-specific models to enhance understanding and treatment of magnesium-wasting renal tubulopathies through innovative functional studies. | ERC Starting... | € 1.500.000 | 2022 | Details |
Deciphering the genetic basis of chronic kidney disease towards prevention and personalized therapyThis project aims to uncover the genetic basis of chronic kidney disease (CKD) through next-generation sequencing and develop RNA-based therapies for targeted treatment and improved management. | ERC Starting... | € 1.800.000 | 2022 | Details |
Linking Ketone Metabolism and Signaling in Heart Failure with Preserved Ejection FractionThis project aims to explore the dual role of ketones in heart failure with preserved ejection fraction, investigating their function as energy sources and protein modifiers to enhance cardiomyocyte health. | ERC Starting... | € 1.809.140 | 2023 | Details |
Decoding diabetic kidney diseaseDECODE-DKD aims to identify novel drug targets for diabetic kidney disease through patient-centric multi-omic research and in-vitro models, advancing precision medicine and treatment options. | ERC Starting... | € 1.783.319 | 2022 | Details |
Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney disease
TargetCKD aims to revolutionize chronic kidney disease management by developing noninvasive diagnostics and novel therapeutics through advanced genomic technologies and interdisciplinary research.
Functional Measurements IN-THE-KIDNEY to Diagnose, Understand and Treat Renal Tubulopathies
This project aims to develop urine-based diagnostics and patient-specific models to enhance understanding and treatment of magnesium-wasting renal tubulopathies through innovative functional studies.
Deciphering the genetic basis of chronic kidney disease towards prevention and personalized therapy
This project aims to uncover the genetic basis of chronic kidney disease (CKD) through next-generation sequencing and develop RNA-based therapies for targeted treatment and improved management.
Linking Ketone Metabolism and Signaling in Heart Failure with Preserved Ejection Fraction
This project aims to explore the dual role of ketones in heart failure with preserved ejection fraction, investigating their function as energy sources and protein modifiers to enhance cardiomyocyte health.
Decoding diabetic kidney disease
DECODE-DKD aims to identify novel drug targets for diabetic kidney disease through patient-centric multi-omic research and in-vitro models, advancing precision medicine and treatment options.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToringThe KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers. | EIC Pathfinder | € 3.080.623 | 2023 | Details |
Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToring
The KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers.